Olema Pharmaceuticals, Inc. (OLMA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -45.99M | -38.33M | -34.53M | -29.88M | -43.98M | -26.28M | -27.02M | -27.55M | -23.5M | -18.48M | -22.74M | -22.12M | -20.39M | -19.71M | -17.99M | -26.46M | -17.9M | -18.6M | -12.1M | -8.9M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -4.57% | -45.82% | -27.8% | -8.45% | -87.18% | -42.26% | -18.78% | -24.59% | -15.23% | 6.27% | -26.41% | 16.41% | -13.9% | -5.96% | -48.72% | -197.13% | -61.52% | -106.4% | -60.54% | - |
| Net Income | -53.09M | -46.06M | -42.22M | -43.78M | -30.39M | -33.57M | -34.55M | -30.38M | -30.97M | -26.77M | -21.5M | -20.09M | -28.29M | -26.18M | -22.72M | -32.86M | -23.03M | -21.64M | -17.71M | -16.41M |
| Depreciation & Amortization | 119K | 187K | 43K | 132K | 128K | 116K | 95K | 94K | 88K | 88K | 90K | 425K | 427K | 97K | 418K | 410K | 407K | 73K | 50K | 31K |
| Stock-Based Compensation | 0 | 4.27M | 4.25M | 4.69M | 4.38M | 6.32M | 5.63M | 5.72M | 4.91M | 4.35M | 4.11M | 0 | 0 | 4.86M | 0 | 0 | 0 | 4.63M | 4.16M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 9.18M | -856K | -1.02M | -1.43M | -1.81M | -1.33M | -1.71M | -1.9M | -2.07M | -1.95M | 320K | 3.08M | 3.76M | -245K | 4.08M | 4.7M | 4.97M | 1.28M | 82K | 3.99M |
| Working Capital Changes | -2.19M | 4.14M | 4.42M | 10.5M | -16.28M | 2.18M | 3.53M | -1.09M | 4.54M | 5.8M | -4.58M | -5.52M | 3.71M | 1.75M | 225K | 1.29M | -251K | -2.94M | 1.33M | 3.48M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -5.68M | 5.77M | 2.39M | 743K | -4.31M | 2.52M | -1.67M | -3.3M | 4.96M | 491K | 582K | 944K | 307K | 360K | -106K | -148K | 245K | -156K | -205K | 5K |
| Cash from Investing | 4.53M | -162.18M | 17.27M | 34.23M | -45.08M | -114.42M | 45.92M | -4.88M | -20.14M | -30.91M | -25.44M | 14.11M | 37.39M | 16.34M | 20.16M | 29.41M | 25.57M | 6M | -12.78M | 10.93M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6K | -153K | 0 | 0 | 0 | 0 | -173K | -139K | -21K | -30K | -699K | -96K | -360K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 45.7M | 213.55M | 41K | -2.52M | 222K | 244.3M | 92K | 15.61M | 8.82M | 523K | 130.63M | 2.04M | 220K | 273K | 106K | 64K | 33K | 818K | 57K | 516K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 50.11M | 213.55M | 41K | 0 | 222K | 243.5M | 92K | 14.89M | 7.9M | -24K | 129.76M | 2.04M | 220K | 0 | 106K | 64K | 33K | 0 | 0 | 516K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -4.41M | 0 | 0 | -2.52M | 0 | 799K | 0 | 719K | 920K | 547K | 869K | 0 | 0 | 273K | 0 | 0 | 0 | 818K | 57K | 0 |
| Net Change in Cash | 4.25M | 13.04M | -17.21M | 1.83M | -88.84M | 103.59M | 19M | -16.83M | -34.82M | -48.87M | 82.45M | -5.96M | 17.22M | -3.1M | 2.28M | 3.02M | 7.7M | -11.79M | -24.82M | 2.54M |
| Free Cash Flow | -45.99M | -38.33M | -34.53M | -29.88M | -43.98M | -26.28M | -27.02M | -27.56M | -23.65M | -18.48M | -22.74M | -22.12M | -20.39M | -19.88M | -18.13M | -26.48M | -17.93M | -19.3M | -12.19M | -9.27M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -4.57% | -45.82% | -27.8% | -8.42% | -85.97% | -42.26% | -18.78% | -24.62% | -15.98% | 7.08% | -25.44% | 16.48% | -13.71% | -3.02% | -48.69% | -185.81% | -55.88% | -112.95% | -62.02% | - |
| FCF per Share | -0.45 | -0.42 | -0.40 | -0.35 | -0.51 | -0.45 | -0.47 | -0.49 | -0.43 | -0.34 | -0.51 | -0.54 | -0.51 | -0.49 | -0.45 | -0.66 | -0.45 | -0.49 | -0.31 | -0.24 |
| FCF Conversion (FCF/Net Income) | 0.87x | 0.83x | 0.82x | 0.68x | 1.45x | 0.78x | 0.78x | 0.91x | 0.76x | 0.69x | 1.06x | 1.10x | 0.72x | 0.75x | 0.79x | 0.81x | 0.78x | 0.86x | 0.68x | 0.54x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |